Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Prostate Cancer

Free Subscription Articles published in Urology Retrieve available abstracts of 276 articles: HTML format

Single Articles

July 2021
1. SESSINE MS, Das S, Park B, Salami SS, et al
   Initial Findings from a High Genetic Risk Prostate Cancer Clinic.
   Urology. 2021 Jul 16. pii: S0090-4295(21)00647.
   PubMed     Abstract available
   
   
   June 2021
2. PIERRE-VICTOR D, Parnes HL, Andriole GL, Pinsky PF, et al
   Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening.
   Urology. 2021 Jun 26. pii: S0090-4295(21)00539.
   PubMed     Abstract available
   
   
   
3. CHANDRASEKAR T, Bowler N, Schneider A, Goldberg H, et al
   Outcomes of Active Surveillance for Men with Intermediate Risk Prostate Cancer, A Population-Based Analysis.
   Urology. 2021 Jun 26. pii: S0090-4295(21)00560.
   PubMed     Abstract available
   
   
   
4. KAWA SM, Stroomberg HV, Larsen SB, Helgstrand JT, et al
   Detection of clinically significant prostate cancer by systematic TRUS-biopsies in a population-based setting over a 20 year period.
   Urology. 2021 Jun 22. pii: S0090-4295(21)00538.
   PubMed     Abstract available
   
   
   
5. CAMPBELL RA, Li J, Malone L, Levy DA, et al
   Correlative Analysis of Vitamin D and Omega-3 Fatty Acid Intake in Men on Active Surveillance for Prostate Cancer.
   Urology. 2021 Jun 15. pii: S0090-4295(21)00525.
   PubMed     Abstract available
   
   
   
6. SOERENSEN SJC, Thomas IC, Schmidt B, Daskivich T, et al
   Reply to the Editorial Comment on: Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration. Urology. 2021.
   Urology. 2021 Jun 14. pii: S0090-4295(21)00488.
   PubMed     Abstract available
   
   
   
7. CHAO B, Lepor H
   5-Year Outcomes Following Focal Laser Ablation of Prostate Cancer.
   Urology. 2021 Jun 3. pii: S0090-4295(21)00460.
   PubMed     Abstract available
   
   
   May 2021
8. HESTERBERG AB, Gordetsky JB, Hurley PJ
   Cribriform Prostate Cancer: Clinical Pathologic and Molecular Considerations.
   Urology. 2021 May 28. pii: S0090-4295(21)00442.
   PubMed     Abstract available
   
   
   
9. KING MC, Sardi A, Velez-Mejia C, Sittig M, et al
   Novel Case of Isolated Peritoneal Carcinomatosis from Metastatic Prostate Cancer Carrying a Pathogenic BRCA Mutation Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
   Urology. 2021 May 25. pii: S0090-4295(21)00435.
   PubMed     Abstract available
   
   
   
10. ARMSTRONG N, Bahl A, Pinkawa M, Ryder S, et al
    SpaceOAR Hydrogel spacer for reducing radiation toxicity during radiotherapy for prostate cancer. A systematic review.
    Urology. 2021 May 22. pii: S0090-4295(21)00421.
    PubMed     Abstract available
    
    
    
11. SCHUBBE ME, Gellhaus PT, Tobert CM, Mott SL, et al
    Knowledge and Attitudes Regarding Surgical Castration in Men Receiving Androgen Deprivation Therapy for Metastatic Prostate Cancer and Their Relationship to Health-Related Quality of Life.
    Urology. 2021 May 7. pii: S0090-4295(21)00368.
    PubMed     Abstract available
    
    
    
12. KF R
    Re: Multi-Institutional Outcomes and Associations after Excision and Primary Anastomosis for Radiotherapy-Associated Bulbomembranous Urethral Stenoses Following Prostate Cancer Treatment.
    Urology. 2021 May 1. pii: S0090-4295(21)00355.
    PubMed    
    
    
    April 2021
13. PAUDEL R, Ferrante S, Qi J, Dunn RL, et al
    Patient preferences and treatment decisions for prostate cancer: Results from a statewide urological quality improvement collaborative.
    Urology. 2021 Apr 29. pii: S0090-4295(21)00350.
    PubMed     Abstract available
    
    
    
14. NORRIS JM, Ball R, Freeman A, Ghei M, et al
    Patient Perspectives and Understanding of MRI-Directed Prostate Cancer Diagnosis.
    Urology. 2021 Apr 3. pii: S0090-4295(21)00301.
    PubMed    
    
    
    February 2021
15. MARCHETTI KA, Oerline M, Hollenbeck BK, Kaufman SR, et al
    Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees.
    Urology. 2021 Feb 18. pii: S0090-4295(21)00182.
    PubMed     Abstract available
    
    
    
16. WOON DTS, Finelli A, Cheung DC, Martin LJ, et al
    A population-based study comparing outcomes for patients with metastatic castrate resistant prostate cancer treated by urologists or medical oncologists with first line abiraterone acetate or enzalutamide.
    Urology. 2021 Feb 13. pii: S0090-4295(21)00172.
    PubMed     Abstract available
    
    
    
17. POSIELSKI NM, Richards KA, Liou JI, Borza T, et al
    Beta-Adrenergic Antagonists and Cancer Specific Survival in Patients with Advanced Prostate Cancer: A Veterans Administration Cohort Study.
    Urology. 2021 Feb 12. pii: S0090-4295(21)00173.
    PubMed     Abstract available
    
    
    
18. HEMAL S, DeWitt-Foy M, Klein EA
    Management of a Prostate Cancer Patient with inherited germline BRCA1 and BRCA2 mutations, a Case Report.
    Urology. 2021 Feb 5. pii: S0090-4295(21)00120.
    PubMed     Abstract available
    
    
    
19. VOELZKE BB, Leddy LS, Myers JB, Breyer BN, et al
    Multi-Institutional Outcomes and Associations after Excision and Primary Anastomosis for Radiotherapy-Associated Bulbomembranous Urethral Stenoses Following Prostate Cancer Treatment.
    Urology. 2021 Feb 5. pii: S0090-4295(21)00121.
    PubMed     Abstract available
    
    
    
20. JIBARA G, Sjoberg DD, Stearns GL, Stabholz Y, et al
    Photoselective Vaporization of the Prostate in the Management of Lower Urinary Tract Symptoms in Prostate Cancer Patients on Active Surveillance.
    Urology. 2021 Feb 1. pii: S0090-4295(21)00112.
    PubMed     Abstract available
    
    
    January 2021
21. MICHAEL J, Khandani AH, Basak R, Tan HJ, et al
    Patterns of recurrence, detection rates, and impact of 18-F Fluciclovine PET/CT on the management of men with recurrent prostate cancer.
    Urology. 2021 Jan 29. pii: S0090-4295(21)00110.
    PubMed     Abstract available
    
    
    
22. HUYNH LM, Keit E, Huang E, Et Al, et al
    Protective Effects of Metformin against Biochemical Failure Following Radical Prostatectomy or Radiation Therapy in Localized Prostate Cancer.
    Urology. 2021 Jan 27. pii: S0090-4295(21)00092.
    PubMed     Abstract available
    
    
    
23. XU J, Bock C, Janisse J, Schwartz KL, et al
    Urologists' Perceptions of Active Surveillance and Their Recommendations for Low-risk Prostate Cancer Patients.
    Urology. 2021 Jan 19. pii: S0090-4295(21)00064.
    PubMed     Abstract available
    
    
    December 2020
24. HOFMANN MR, Hussain M, Dehm SM, Beltran H, et al
    Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer Biomarker Working Group Meeting Summary.
    Urology. 2020 Dec 26. pii: S0090-4295(20)31519.
    PubMed     Abstract available
    
    
    
25. HANDLEY NR, Feng FY, Guise TA, D'Andrea D, et al
    Preserving Well-being in Patients With Advanced and Late Prostate Cancer.
    Urology. 2020 Dec 26. pii: S0090-4295(20)31513.
    PubMed     Abstract available
    
    
    
26. MCMAHON S, Basak R, Zhou X, Smith AB, et al
    Patient-Reported Health Status, Comorbidity Burden, and Prostate Cancer Treatment.
    Urology. 2020 Dec 19. pii: S0090-4295(20)31498.
    PubMed     Abstract available
    
    
    
27. ALANEE S, Peabody J, Menon M
    Prostate Cancer Undetected by mpMRI: Tumour Conspicuity is Reliant Upon Optimal Scan Timing and Quality.
    Urology. 2020 Dec 3. pii: S0090-4295(20)31428.
    PubMed    
    
    
    
28. NORRIS JM, Allen C, Ball R, Freeman A, et al
    Prostate Cancer Undetected by mpMRI: Tumour Conspicuity is Reliant Upon Optimal Scan Timing and Quality.
    Urology. 2020 Dec 2. pii: S0090-4295(20)31427.
    PubMed    
    
    
    November 2020
29. SCHMANKE K, Okut H, Ablah E
    Trends for Stage and Grade Group of Prostate Cancer in the US (2010-2016).
    Urology. 2020 Nov 20. pii: S0090-4295(20)31399.
    PubMed     Abstract available
    
    
    
30. BHATTU AS, Zappala SM, Parekh DJ, Punnen S, et al
    A 4Kscore cut-off of 7.5% for prostate biopsy decisions provides high sensitivity and negative predictive value for significant prostate cancer.
    Urology. 2020 Nov 17. pii: S0090-4295(20)31371.
    PubMed     Abstract available
    
    
    
31. GREENBERG JW, Leinwand G, Feibus AH, Haney NM, et al
    Prospective Observational Study of a Racially Diverse Group of Men on Active Surveillance for Prostate Cancer.
    Urology. 2020 Nov 6. pii: S0090-4295(20)31346.
    PubMed     Abstract available
    
    
    October 2020
32. SOETERIK TFW, van Melick HHE, Dijksman LM, Biesma DH, et al
    Multi-parametric magnetic resonance imaging should be preferred over digital rectal examination for prostate cancer local staging and disease risk classification.
    Urology. 2020 Oct 28. pii: S0090-4295(20)31296.
    PubMed     Abstract available
    
    
    
33. DE ALMEIDA RVS, Silvino JRC, Kalil JR, Junior VLDS, et al
    Early Effects of High-Intensity Focused Ultrasound (HIFU) Treatment for Prostate Cancer on Fecal Continence and Anorectal Physiology.
    Urology. 2020 Oct 17. pii: S0090-4295(20)31265.
    PubMed     Abstract available
    
    
    September 2020
34. WINOKER JS, Wajswol E, Falagario U, Maritini A, et al
    Transperineal versus transrectal targeted biopsy with use of electromagnetically-tracked MR/US fusion guidance platform for the detection of clinically significant prostate cancer.
    Urology. 2020 Sep 18. pii: S0090-4295(20)31137.
    PubMed     Abstract available
    
    
    
35. GINSBURG KB, Jacobs JC, Qi J, Kaye DR, et al
    Impact of Early Confirmatory Tests on Upgrading and Conversion to Treatment in Prostate Cancer Patients on Active Surveillance.
    Urology. 2020 Sep 15. pii: S0090-4295(20)31125.
    PubMed     Abstract available
    
    
    
36. ALANEE S, Deebajah M, Taneja K, Cole D, et al
    Post prostatectomy Pathologic Findings of Patients with Clinically Significant Prostate Cancer and no Significant PI-RADS Lesions on Preoperative Magnetic Resonance Imaging.
    Urology. 2020 Sep 15. pii: S0090-4295(20)31127.
    PubMed     Abstract available
    
    
    
37. SHIRK JD
    RE: 3D Printing, Augmented Reality, and Virtual Reality for the Assessment and Management of Kidney and Prostate Cancer: A Systematic Review.
    Urology. 2020 Sep 9. pii: S0090-4295(20)31012.
    PubMed    
    
    
    August 2020
38. KARSIYAKALI N, Ozgen MB, Ozveren B, Akbal C, et al
    Sub-optimal Prediction of Clinically Significant Prostate Cancer in Radical Prostatectomy Specimens by mpMRI-Targeted Biopsy.
    Urology. 2020 Aug 29. pii: S0090-4295(20)31028.
    PubMed     Abstract available
    
    
    
39. THOMAS L, Sharifi N
    Germline HSD3B1 Genetics and Prostate Cancer Outcomes.
    Urology. 2020 Aug 28. pii: S0090-4295(20)31025.
    PubMed     Abstract available
    
    
    
40. WAKE N, Bjurlin MA
    Author Reply: 3D Printing, Augmented Reality, and Virtual Reality for the Assessment and Management of Kidney and Prostate Cancer: A Systematic Review.
    Urology. 2020 Aug 28. pii: S0090-4295(20)31010.
    PubMed    
    
    
    
41. LAMBA N, Butler S, Mahal BA, Trinh QD, et al
    Three-tiered sub-classification system of high-risk prostate cancer in men managed with radical prostatectomy: Implications for treatment decision-making.
    Urology. 2020 Aug 4. pii: S0090-4295(20)30949.
    PubMed     Abstract available
    
    
    
42. KAHOKEHR AA, Boysen WR, Schild MH, Nose BD, et al
    Urinary pubic symphysis fistula leads to histopathologic osteomyelitis in prostate cancer survivors.
    Urology. 2020 Aug 4. pii: S0090-4295(20)30947.
    PubMed     Abstract available
    
    
    July 2020
43. WU Y, Wang Y, Gu Y, Xia J, et al
    Prostate Cancer Risk and Prognostic Influence Among Users of 5-Alpha-Reductase Inhibitors and Alpha-Blockers: A Systematic Review and Meta-Analysis.
    Urology. 2020 Jul 31. pii: S0090-4295(20)30932.
    PubMed     Abstract available
    
    
    
44. CIPRUT SE, Kelly MD, Walter D, Hoffman R, et al
    A Clinical Reminder Order Check (CROC) Intervention to Improve Guideline-Concordant Imaging Practices for men with Prostate Cancer: A Pilot Study.
    Urology. 2020 Jul 25. pii: S0090-4295(20)30888.
    PubMed     Abstract available
    
    
    
45. BARQAWI A, Pessoa RR, Al-Musawi M, MacDermott T, et al
    THE IMPACT OF PERFORMING A 3D MAPPING BIOPSY PRIOR TO PRIMARY CRYOTHERAPY FOR THE TREATMENT OF PROSTATE CANCER.
    Urology. 2020 Jul 22. pii: S0090-4295(20)30867.
    PubMed     Abstract available
    
    
    
46. MATSUGASUMI T, Shiraishi T, Fujihara A, Ohashi M, et al
    Targeted focal cryoablation for prostate cancer with real-time Transrectal Ultrasound guided free-hands technique: A step-by-step technique.
    Urology. 2020 Jul 16. pii: S0090-4295(20)30847.
    PubMed     Abstract available
    
    
    
47. O'CONNOR LP, Wang AZ, Yerram NK, Lebastchi AH, et al
    Combined MRI-targeted plus systematic confirmatory biopsy improves risk stratification for patients enrolling on active surveillance for prostate cancer.
    Urology. 2020 Jul 14. pii: S0090-4295(20)30828.
    PubMed     Abstract available
    
    
    
48. YAN H, Dittmar F, Schagdarsurengin U, Wagenlehner F, et al
    The clinical application and potential roles of circulating tumor cells in bladder cancer and prostate cancer.
    Urology. 2020 Jul 4. pii: S0090-4295(20)30799.
    PubMed     Abstract available
    
    
    June 2020
49. WAKE N, Nussbaum JE, Elias MI, Nikas CV, et al
    3D Printing, Augmented Reality, and Virtual Reality for the Assessment and Management of Kidney and Prostate Cancer: A Systematic Review.
    Urology. 2020 Jun 11. pii: S0090-4295(20)30663.
    PubMed     Abstract available
    
    
    
50. CULLEN J, Kuo HC, Shan J, Lu R, et al
    The 17-Gene Genomic Prostate Score Test as a Predictor of Outcomes in Men with Unfavorable Intermediate Risk Prostate Cancer.
    Urology. 2020 Jun 7. pii: S0090-4295(20)30623.
    PubMed     Abstract available
    
    
    
51. KAUFMAN ME, Miller DT, Ullah A, White J, et al
    Skene's Gland Adenocarcinoma: Borrowing from Prostate Cancer Experience for the Evaluation and Management of a Rare Malignancy.
    Urology. 2020 Jun 3. pii: S0090-4295(20)30632.
    PubMed     Abstract available
    
    
    May 2020
52. IINUMA K, Nakano M, Kato T, Kato D, et al
    Assessment of long-term changes in lower urinary tract symptoms in patients with prostate cancer who underwent low-dose-rate prostate brachytherapy.
    Urology. 2020 May 13. pii: S0090-4295(20)30540.
    PubMed     Abstract available
    
    
    
53. NOSE BD, Boysen WR, Kahokehr AA, Inouye BM, et al
    Extirpative cultures reveal infectious pubic bone osteomyelitis in prostate cancer survivors with urinary-pubic symphysis fistulae (UPF).
    Urology. 2020 May 7. pii: S0090-4295(20)30520.
    PubMed     Abstract available
    
    
    April 2020
54. FROEHNER M, Koch R, Hubler M, Lindner M, et al
    Quantifying the relationship between increasing life expectancy and non-prostate cancer mortality after radical prostatectomy.
    Urology. 2020 Apr 22. pii: S0090-4295(20)30435.
    PubMed     Abstract available
    
    
    
55. PARTIN AW
    Commentary RE: Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium & Updated Nomogram to Predict Pathologic Stage of Prostate Cancer Given Prostate-Specific Antigen Level, Clinical Stage, and Biopsy Glea
    Urology. 2020 Apr 17. pii: S0090-4295(20)30422.
    PubMed    
    
    
    
56. BARRY M, Fowler J
    Commentary RE: Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey.
    Urology. 2020 Apr 16. pii: S0090-4295(20)30401.
    PubMed    
    
    
    
57. WYSOCK JS, Becher E, Persily J, Loeb S, et al
    Concordance and Performance of 4Kscore(R) and SelectMDx(R) for Informing Decision to Perform Prostate Biopsy and Detection of Prostate Cancer.
    Urology. 2020 Apr 12. pii: S0090-4295(20)30339.
    PubMed     Abstract available
    
    
    March 2020
58. RYG U, Lilleby W, Hole KH, Lund-Iversen M, et al
    Local Recurrence of Prostate Cancer to the Intersphincteric Space: A Case Report.
    Urology. 2020 Mar 18. pii: S0090-4295(20)30275.
    PubMed    
    
    
    
59. AGARD H, Clark C, Massanyi E, Steele M, et al
    Chemoradiotherapy-induced Cytodifferentiation in Bladder/Prostate Rhabdomyosarcoma With Genetic Downregulation of Myogenin and MyoD1 Gene Expression: A Case Study and Review of the Literature.
    Urology. 2020;137:173-177.
    PubMed     Abstract available
    
    
    
60. PLOUSSARD G, Beauval JB, Lesourd M, Almeras C, et al
    Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies.
    Urology. 2020;137:126-132.
    PubMed     Abstract available
    
    
    
61. HALSTEAD NV, Cost NG, Hecht SL, Walker JP, et al
    Neurofibromatosis-1 and Rhabdomyosarcoma: An Unusual Recurrence.
    Urology. 2020;137:168-172.
    PubMed     Abstract available
    
    
    
62. DEWITT-FOY ME, Klein EA, ElShafei A, Coronado WM, et al
    The Association of Urologic Oncology Fellowship Training and Diagnostic Yield of Prostate Biopsy.
    Urology. 2020;137:115-120.
    PubMed     Abstract available
    
    
    
63. PEPE P, Pennisi M, Fraggetta F
    How Many Cores Should be Obtained During Saturation Biopsy in the Era of Multiparametric Magnetic Resonance? Experience in 875 Patients Submitted to Repeat Prostate Biopsy.
    Urology. 2020;137:133-137.
    PubMed     Abstract available
    
    
    
64. IAKYMENKO OA, Lugo I, Kwon D, Zhao W, et al
    Prostatic Ductal Adenocarcinoma Controlled for Cancer Grade and Tumor Volume Does Not Have an Independent Effect on Adverse Radical Prostatectomy Outcomes Compared to Usual Acinar Prostatic Adenocarcinoma.
    Urology. 2020;137:108-114.
    PubMed     Abstract available
    
    
    
65. GRINBERG AS, Sellinger JJ, Sprenkle PC, Bandin AJ, et al
    Effect of Diaphragmatic Breathing on Procedural Anxiety During Transrectal Prostate Biopsy.
    Urology. 2020;137:26-32.
    PubMed     Abstract available
    
    
    February 2020
66. CIEZKI JP
    EDITORIAL COMMENT.
    Urology. 2020;136:188-189.
    PubMed    
    
    
    
67. DAS H, Rodriguez R
    Health Care Disparities in Urologic Oncology: A Systematic Review.
    Urology. 2020;136:9-18.
    PubMed     Abstract available
    
    
    
68. ZHANG F, Fu Y, Chen M, Wang F, et al
    Renal Pelvis Metastasis From Prostatic Adenocarcinoma Missed by PSMA PET: A Case Report.
    Urology. 2020;136:e3-e4.
    PubMed     Abstract available
    
    
    January 2020
69. HUANG MM, Macura KJ, Landis P, Epstein JI, et al
    Evaluation of apparent diffusion coefficient as a predictor of grade reclassification in men on active surveillance for prostate cancer.
    Urology. 2020 Jan 15. pii: S0090-4295(20)30018.
    PubMed     Abstract available
    
    
    
70. JACOBS BL, Yabes JG, Lopa SH, Heron DE, et al
    The development and validation of prostate cancer-specific physician-hospital networks.
    Urology. 2020 Jan 13. pii: S0090-4295(20)30012.
    PubMed     Abstract available
    
    
    
71. AL HUSSEIN AL AWAMLH B, Ma X, Scherr D, Hu JC, et al
    Temporal Changes in Demographic and Clinical Characteristics of Men With Prostate Cancer Electing for Conservative Management in the United States.
    Urology. 2020 Jan 13. pii: S0090-4295(19)31106.
    PubMed     Abstract available
    
    
    
72. ALSHAK MN, Patel N, Gross MD, Margolis D, et al
    Persistent Discordance in Grade, Stage, and NCCN Risk Stratification in Men Undergoing Targeted Biopsy and Radical Prostatectomy.
    Urology. 2020;135:117-123.
    PubMed     Abstract available
    
    
    
73. HARPER SN, Hale LP, Ferrandino MN, Moul JW, et al
    Acute Presentation of Previously Unrecognized Congenital Ureteropelvic Junction Obstruction 5 Weeks After Radical Retropubic Prostatectomy.
    Urology. 2020;135:20-23.
    PubMed    
    
    
    December 2019
74. MOON SK, You MW, Lim JW
    Granulomatous Prostatitis Mimicking Prostate Cancer.
    Urology. 2019 Dec 30. pii: S0090-4295(19)31136.
    PubMed     Abstract available
    
    
    
75. GUPTA I, Freid B, Masarapu V, Machado P, et al
    Transrectal Subharmonic Ultrasound Imaging for Prostate Cancer Detection.
    Urology. 2019 Dec 30. pii: S0090-4295(19)31132.
    PubMed     Abstract available
    
    
    
76. ACHARD V, Achard G, Friedlaender A, Roth A, et al
    Prostate cancer non-ascitic peritoneal carcinomatosis after robot-assisted laparoscopic radical prostatectomy: three case reports and review of the literature.
    Urology. 2019 Dec 5. pii: S0090-4295(19)31095.
    PubMed     Abstract available
    
    
    
77. SETIA S, Feng C, Coogan C, Vourganti S, et al
    Urology Residents' Experience With Simulation: Initial Evaluation of MRI/US Fusion Biopsy Workshop.
    Urology. 2019;134:51-55.
    PubMed     Abstract available
    
    
    
78. HENNING GM, Vetter JM, Drake BF, Ippolito JE, et al
    Diagnostic Performance of Prostate Multiparametric Magnetic Resonance Imaging in African-American Men.
    Urology. 2019;134:181-185.
    PubMed     Abstract available
    
    
    November 2019
79. LEE HH, Shaw N, Mohammed S, Kowalczyk K, et al
    Prostate Cancer in Men with Treated Advanced Heart Failure: Should we keep Screening?
    Urology. 2019 Nov 28. pii: S0090-4295(19)31047.
    PubMed     Abstract available
    
    
    
80. SCHWARZMAN LS, Pagani RL, Ohlander SJ, Mima M, et al
    Diagnostic properties of total and free prostate-specific antigen to predict overall and clinically significant prostate cancer among men with low testosterone and prior negative biopsy.
    Urology. 2019 Nov 13. pii: S0090-4295(19)30972.
    PubMed     Abstract available
    
    
    
81. FRANKCOMBE DE, Li J, Cohen RJ
    Redefining the Concept of Clinically Insignificant Prostate Cancer.
    Urology. 2019 Nov 9. pii: S0090-4295(19)30964.
    PubMed     Abstract available
    
    
    
82. LEONG JY, Herrera-Caceres JO, Goldberg H, Tham E, et al
    Questioning the status quo: Should Gleason Grade Group 1 prostate cancer be considered a "negative core" in pre-radical prostatectomy risk nomograms? An international multicenter analysis.
    Urology. 2019 Nov 6. pii: S0090-4295(19)30949.
    PubMed     Abstract available
    
    
    
83. GOY BW, Burchette R, Soper MS, Chang T, et al
    Ten-Year Treatment Outcomes of Radical Prostatectomy vs External Beam Radiation Therapy vs Brachytherapy for 1,503 Patients with Intermediate Risk Prostate Cancer.
    Urology. 2019 Nov 5. pii: S0090-4295(19)30943.
    PubMed     Abstract available
    
    
    
84. LAM JS
    Editorial Comment.
    Urology. 2019;133:185.
    PubMed    
    
    
    
85. LEPOR H
    EDITORIAL COMMENT.
    Urology. 2019;133:179.
    PubMed    
    
    
    
86. LLORENS DE KNECHT E, Guadarrama Vega S, Donate G, Palou Redorta J, et al
    Robot-assisted Radical Prostatectomy Due to a Primary Carcinoid Prostatic Tumor in a Three-Year-Old Child: A Case Report.
    Urology. 2019;133:216-218.
    PubMed     Abstract available
    
    
    
87. TRABULSI EJ, Calio BP, Kamel SI, Gomella LG, et al
    Prostate Contrast Enhanced Transrectal Ultrasound Evaluation of the Prostate With Whole-Mount Prostatectomy Correlation.
    Urology. 2019;133:187-191.
    PubMed     Abstract available
    
    
    October 2019
88. ROONEY MK, Morgans AK, Chen RC, Golden DW, et al
    Educational material on prostate cancer screening is overly complex and fails to meet recommended layperson readability guidelines.
    Urology. 2019 Oct 24. pii: S0090-4295(19)30922.
    PubMed    
    
    
    
89. KAIHO Y, Ito J, Iwamura H, Anan G, et al
    Nerves in the Areas Posterior to the Prostate Base Contribute to Erectile Function: An Intraoperative Electrical Stimulation Assessment.
    Urology. 2019;132:156-160.
    PubMed     Abstract available
    
    
    
90. LEONG JY, Chandrasekar T, Sebastiano C, Rshaidat H, et al
    Prostatic Stromal Tumors of Uncertain Malignant Potential.
    Urology. 2019;132:e3-e4.
    PubMed     Abstract available
    
    
    
91. KAZMI Z, Sulaiman N, Shaukat M, Rafi A, et al
    Atypical Presentation of Seminoma in the Prostate - Case Report.
    Urology. 2019;132:33-36.
    PubMed    
    
    
    September 2019
92. MACNEIL J, Maclean F, Delprado W
    Pathological characteristics of prostate cancer occurring in younger men: a retrospective study of prostatectomy patients.
    Urology. 2019 Sep 18. pii: S0090-4295(19)30808.
    PubMed     Abstract available
    
    
    
93. GRONDHUIS PALACIOS LA, van Zanten P, den Ouden MEM, Krouwel EM, et al
    Discrepancy between Expectations and Experiences after Prostate Cancer Treatment: A Dutch Multicenter Study.
    Urology. 2019 Sep 5. pii: S0090-4295(19)30796.
    PubMed     Abstract available
    
    
    
94. JI C, Wang W, Lu Q, Fu Y, et al
    A new technique in fresh prostate cancer tissue biobanking based on MRI-transrectal ultrasound fusion biopsy.
    Urology. 2019 Sep 2. pii: S0090-4295(19)30751.
    PubMed     Abstract available
    
    
    
95. REICHARD CA, Chapin BF
    Editorial Comment.
    Urology. 2019;131:174.
    PubMed    
    
    
    
96. ANSCHER MS
    EDITORIAL COMMENT.
    Urology. 2019;131:164-165.
    PubMed    
    
    
    
97. WANGERIN K, Iagaru A
    (68)Ga Scatter Correction to Eliminate Halo-Artifacts in PET Imaging.
    Urology. 2019;131:262.
    PubMed    
    
    
    
98. BALAKRISHNAN AS, Zhao S, Cowan JE, Broering JM, et al
    Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor.
    Urology. 2019;131:157-165.
    PubMed     Abstract available
    
    
    
99. CARAM MEV, Kaufman SR, Modi PK, Herrel L, et al
    Adoption of Abiraterone and Enzalutamide by Urologists.
    Urology. 2019;131:176-183.
    PubMed     Abstract available
    
    
    August 2019
100. ARABI A, Deebaja M, Yaguchi G, Pantelic M, et al
     Systematic biopsy does not contribute to disease upgrading in patients undergoing targeted biopsy for PI-RADS 5 lesions identified on magnetic resonance imaging in the course of active surveillance for prostate cancer.
     Urology. 2019 Aug 31. pii: S0090-4295(19)30789.
     PubMed     Abstract available
     
     
     
101. PENG LC, Mian OY, Lakshminarayanan P, Huang P, et al
     Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer.
     Urology. 2019 Aug 24. pii: S0090-4295(19)30732.
     PubMed     Abstract available
     
     
     
102. JOHNSTON MJ, Emara A, Noureldin M, Bott S, et al
     Focal high-intensity focussed ultrasound partial gland ablation for the treatment of localised prostate cancer: a report of medium-term outcomes from a single-centre in the United Kingdom.
     Urology. 2019 Aug 23. pii: S0090-4295(19)30730.
     PubMed     Abstract available
     
     
     
103. GHABILI K, Swallow M, Sherrer RL, Syed JS, et al
     Association between Tumor Multifocality on Multi-parametric MRI and Detection of Clinically-Significant Prostate Cancer in Lesions with Prostate Imaging Reporting and Data System (PI-RADS) Score 4.
     Urology. 2019 Aug 13. pii: S0090-4295(19)30716.
     PubMed     Abstract available
     
     
     
104. SAMMON JD, Trinh QD
     EDITORIAL COMMENT.
     Urology. 2019;130:84-85.
     PubMed    
     
     
     
105. UNWALA DJ
     Editorial Comment.
     Urology. 2019;130:104-105.
     PubMed    
     
     
     
106. DAI C, Ganesan V, Nyame YA, Almassi N, et al
     Older Age at Diagnosis and Initial Disease Volume Predict Grade Reclassification Risk on Confirmatory Biopsy in Patients Considered for Active Surveillance.
     Urology. 2019;130:106-112.
     PubMed     Abstract available
     
     
     
107. SHELTON JB, Paivanas TA, Buffington P, Ruyle SR, et al
     Three-year Active Surveillance Outcomes in a Contemporary Community Urology Cohort in the United States.
     Urology. 2019;130:72-78.
     PubMed     Abstract available
     
     
     
108. ALVES LJ, Gameiro CD, Lopes SP, Ascensao JB, et al
     Prostate Leiomyosarcoma: A Rare Misleading Tumor.
     Urology. 2019;130:13-16.
     PubMed     Abstract available
     
     
     July 2019
109. PENA A, Qian Z, Lambrechts S, Cabri JN, et al
     Evaluation of implementation outcomes after initiation of a shared decision-making program for men with prostate cancer.
     Urology. 2019 Jul 9. pii: S0090-4295(19)30608.
     PubMed     Abstract available
     
     
     
110. SINGLA N, Margulis V
     EDITORIAL COMMENT.
     Urology. 2019;129:85.
     PubMed    
     
     
     
111. HEIDENREICH A, Rieke M
     Editorial Comment.
     Urology. 2019;129:163.
     PubMed    
     
     
     
112. STRAND D
     EDITORIAL COMMENT.
     Urology. 2019;129:163-164.
     PubMed    
     
     
     
113. LOPES VENDRAMI C, McCarthy RJ, Chatterjee A, Casalino D, et al
     The Utility of Prostate Specific Antigen Density, Prostate Health Index, and Prostate Health Index Density in Predicting Positive Prostate Biopsy Outcome is Dependent on the Prostate Biopsy Methods.
     Urology. 2019;129:153-159.
     PubMed     Abstract available
     
     
     June 2019
114. MORENO JG, Gomella LG
     Evolution of the Liquid Biopsy in Metastatic Prostate Cancer.
     Urology. 2019 Jun 14. pii: S0090-4295(19)30535.
     PubMed     Abstract available
     
     
     
115. MARTIN SE, Begun EM, Samir E, Azaiza MT, et al
     Incidence and Morbidity of Radiation-Induced Hemorrhagic Cystitis in Prostate Cancer.
     Urology. 2019 Jun 12. pii: S0090-4295(19)30513.
     PubMed     Abstract available
     
     
     
116. HOFFMANN MA, Wieler HJ, Baues C, Kuntz NJ, et al
     Letter-to-the-Editor Reply: "The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer": "68Ga Scatter Correction to Eliminate Halo-Artifacts in PET Imaging".
     Urology. 2019 Jun 11. pii: S0090-4295(19)30517.
     PubMed    
     
     
     
117. JACOBS BL, Lopa SH, Yabes JG, Nelson JB, et al
     Change in functional status after prostate cancer treatment among Medicare Advantage beneficiaries.
     Urology. 2019 Jun 7. pii: S0090-4295(19)30508.
     PubMed     Abstract available
     
     
     
118. LAN T, Chen Y, Su Q, Ye J, et al
     Oncological outcome of cytoreductive radical prostatectomy in prostate cancer patients with bone oligometastases.
     Urology. 2019 Jun 7. pii: S0090-4295(19)30507.
     PubMed     Abstract available
     
     
     May 2019
119. PICKERSGILL NA, Vetter JM, Raval NS, Andriole GL, et al
     The Accuracy of Prostate Magnetic Resonance Imaging Interpretation: Impact of the Individual Radiologist and Clinical Factors.
     Urology. 2019;127:68-73.
     PubMed     Abstract available
     
     
     
120. BEKSAC AT, Sobotka S, Xu P, Gupta A, et al
     Downgrading of Grade Group After Radical Prostatectomy: Comparison of Multiparametric Magnetic Resonance Imaging Guided Fusion Biopsy and Standard 12-Core Biopsy.
     Urology. 2019;127:80-85.
     PubMed     Abstract available
     
     
     April 2019
121. DRAULANS C, Everaerts W, Isebaert S, Gevaert T, et al
     Impact of MRI on prostate cancer staging and EAU risk classification.
     Urology. 2019 Apr 30. pii: S0090-4295(19)30386.
     PubMed     Abstract available
     
     
     
122. MAY A, Henke J, Au D, Raza SJ, et al
     National trends in the utilization of androgen deprivation therapy for very low risk prostate cancer.
     Urology. 2019 Apr 29. pii: S0090-4295(19)30366.
     PubMed     Abstract available
     
     
     
123. MODI PK, Herrel LA, Kaufman SR, Yan P, et al
     Urologist practice structure and spending for prostate cancer care.
     Urology. 2019 Apr 25. pii: S0090-4295(19)30372.
     PubMed     Abstract available
     
     
     
124. HOFFMANN MA, Wieler HJ, Baues C, Kuntz NJ, et al
     The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer.
     Urology. 2019 Apr 12. pii: S0090-4295(19)30342.
     PubMed     Abstract available
     
     
     
125. SHELTON JB, Buffington P, Augspurger R, Gaylis F, et al
     Contemporary Management of Incident Prostate Cancer in Large Community Urology Practices in the United States.
     Urology. 2019 Apr 4. pii: S0090-4295(19)30326.
     PubMed     Abstract available
     
     
     
126. SINGHAL U, Morgan TM, Tosoian JJ
     EDITORIAL COMMENT.
     Urology. 2019;126:82.
     PubMed    
     
     
     
127. GEJERMAN G
     Editorial Comment.
     Urology. 2019;126:151.
     PubMed    
     
     
     
128. STEINBERG RL, Johnson BA, Cadeddu JA
     Magnetic-assisted Robotic Surgery to Facilitate Reduced-port Radical Prostatectomy.
     Urology. 2019;126:237.
     PubMed     Abstract available
     
     
     March 2019
129. FAM MM, Yabes JG, Macleod LC, Bandari J, et al
     Increasing Utilization of Multi-Parametric Magnetic Resonance Imaging in Prostate Cancer Active Surveillance.
     Urology. 2019 Mar 30. pii: S0090-4295(19)30321.
     PubMed     Abstract available
     
     
     
130. BRYK DJ, Angermeier KW, Klein EA
     A Case of Metastatic Prostate Cancer to the Urethra that Resolved after Androgen Deprivation Therapy.
     Urology. 2019 Mar 29. pii: S0090-4295(19)30323.
     PubMed     Abstract available
     
     
     
131. ROCCO B, Sighinolfi MC, Sandri M, Eissa A, et al
     Is Extraprostatic Extension of Cancer Predictable? A Review of Predictive Tools and an External Validation based on a Large and a Single Center Cohort of Prostate Cancer Patients.
     Urology. 2019 Mar 27. pii: S0090-4295(19)30316.
     PubMed     Abstract available
     
     
     
132. BORETA L, Gadzinski AJ, Wu SY, Xu M, et al
     Location of recurrence by Gallium-68 PSMA-11 PET scan in prostate cancer patients eligible for salvage radiotherapy.
     Urology. 2019 Mar 27. pii: S0090-4295(19)30262.
     PubMed     Abstract available
     
     
     
133. FREITAS D, Andriole GL, Freedland SJ, Neto BS, et al
     Baseline basal cell hyperplasia is not associated with baseline lower urinary tract symptoms, baseline clinical prostatitis or prostate cancer in repeat biopsies.
     Urology. 2019 Mar 23. pii: S0090-4295(19)30312.
     PubMed     Abstract available
     
     
     
134. HEIDENREICH A
     Editorial Comment.
     Urology. 2019;125:160-161.
     PubMed    
     
     
     
135. ARNOLD MJ
     Concerns With "New Evidence for the Benefits of Prostate-specific Antigen Screening: Data from 400,887 Kaiser Permanente Patients".
     Urology. 2019;125:261.
     PubMed    
     
     
     
136. ALPERT PF
     Reply by Author: "New Evidence for the Benefits of Prostate-Specific Antigen Screening".
     Urology. 2019;125:261-262.
     PubMed    
     
     
     February 2019
137. ASAFU-ADJEI D, Mikkilineni N, Sebesta E, Hyams E, et al
     Misinformation on the Internet regarding Ablative Therapies for Prostate Cancer.
     Urology. 2019 Feb 25. pii: S0090-4295(19)30205.
     PubMed     Abstract available
     
     
     
138. EINSTEIN DJ, Patil D, Chipman J, Regan MM, et al
     Expanded Prostate Cancer Index Composite-26 (EPIC-26) Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life after Treatment for Localized Prostate Cancer.
     Urology. 2019 Feb 18. pii: S0090-4295(19)30152.
     PubMed     Abstract available
     
     
     
139. TANIGUCHI H, Kawakita S, Kinoshita H, Murota T, et al
     Testosterone Profiles after Brachytherapy for Localized Prostate Cancer.
     Urology. 2019 Feb 1. pii: S0090-4295(19)30089.
     PubMed     Abstract available
     
     
     
140. MODI PK
     EDITORIAL COMMENT.
     Urology. 2019;124:105-106.
     PubMed    
     
     
     January 2019
141. PIKE LRG, Wu J, Chen MH, Loffredo M, et al
     Time to PSA Nadir and the Risk of Death from Prostate Cancer following Radiation and Androgen Deprivation Therapy.
     Urology. 2019 Jan 18. pii: S0090-4295(19)30066.
     PubMed     Abstract available
     
     
     
142. LOH-DOYLE JC, Ashrafi A, Nazemi A, Ghodoussipour S, et al
     Dual Prosthetic Implantation After Radical Cystoprostatectomy and Neobladder: Outcomes of the Inflatable Penile Prosthesis and Artificial Urinary Sphincter in Bladder Cancer Survivors.
     Urology. 2019 Jan 18. pii: S0090-4295(19)30065.
     PubMed     Abstract available
     
     
     
143. ZHOU SR, Simopoulos DN, Jayadevan R, Felker ER, et al
     USE OF MRI-GUIDED BIOPSY FOR SELECTION AND FOLLOW-UP OF MEN UNDERGOING HEMI-GLAND CRYOABLATION OF PROSTATE CANCER.
     Urology. 2019 Jan 16. pii: S0090-4295(19)30058.
     PubMed     Abstract available
     
     
     
144. EGGENER S, Karsh LI, Richardson T, Shindel AW, et al
     A 17-gene Panel for Prediction of Adverse Prostate Cancer Pathologic Features: Prospective Clinical Validation and Utility.
     Urology. 2019 Jan 3. pii: S0090-4295(19)30001.
     PubMed     Abstract available
     
     
     
145. PURYSKO AS
     Editorial comment.
     Urology. 2019;123:196-197.
     PubMed    
     
     
     
146. RAMIREZ-BACKHAUS M, Bertolo R, Mamber A, Ferrer AG, et al
     Live Surgery for Laparoscopic Radical Prostatectomy-Does it Worsen the Outcomes? A Single-center Experience.
     Urology. 2019;123:133-139.
     PubMed     Abstract available
     
     
     
147. LI R, Zhang M, Duplisea JJ, Troncoso P, et al
     Detection and Treatment of Primary Prostatic Melanoma.
     Urology. 2019;123:16-19.
     PubMed     Abstract available
     
     
     
148. KAYE DR, Ye Z, Li J, Herrel LA, et al
     The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive Program.
     Urology. 2019;123:114-119.
     PubMed     Abstract available
     
     
     December 2018
149. HEIDENREICH A
     WITHDRAWN: Impact of Staging 68Ga-PSMA-11 PET scans on radiation treatment plans in patients with prostate cancer by Thomas Hope et al.
     Urology. 2018 Dec 21. pii: S0090-4295(18)31326.
     PubMed    
     
     
     
150. CHANG EM, Punglia RS, Steinberg ML, Raldow AC, et al
     Cost Effectiveness of the Oncotype DX Genomic Prostate Score for Guiding Treatment Decisions in Patients With Early Stage Prostate Cancer.
     Urology. 2018 Dec 20. pii: S0090-4295(18)31334.
     PubMed     Abstract available
     
     
     
151. BHAT NR, Vetter JM, Andriole GL, Shetty AS, et al
     MRI-Defined PSA Density Significantly Improves the Risk Prediction for Clinically Significant Prostate Cancer on Biopsy.
     Urology. 2018 Dec 20. pii: S0090-4295(18)31324.
     PubMed     Abstract available
     
     
     
152. WU SY, Boreta L, Shinohara K, Nguyen H, et al
     Impact of staging (68)Ga-PSMA-11 PET scans on radiation treatment plans in patients with prostate cancer.
     Urology. 2018 Dec 20. pii: S0090-4295(18)31321.
     PubMed     Abstract available
     
     
     
153. MARTIN DT, Ghabili K, Levi A, Humphrey PA, et al
     Prostate Cancer Genomic Classifier Relates More Strongly to Gleason Grade Group than PI-RADS Score in Multi-Parametric Prostate MRI-Ultrasound Fusion Targeted Biopsies.
     Urology. 2018 Dec 12. pii: S0090-4295(18)31306.
     PubMed     Abstract available
     
     
     November 2018
154. CHEN J, Wang ZJ, Zhang KL, Xu YJ, et al
     Selective castration-resistant prostate cancer photothermal ablation with CuS nanoplates.
     Urology. 2018 Nov 21. pii: S0090-4295(18)31215.
     PubMed     Abstract available
     
     
     
155. CHEN Q, Sun T, Wang F, Gong B, et al
     Long noncoding RNA IGF2AS is acting as an epigenetic tumor suppressor in human prostate cancer.
     Urology. 2018 Nov 10. pii: S0090-4295(18)31137.
     PubMed     Abstract available
     
     
     October 2018
156. QUARRIER SO, Matloubieh JE, Wu G
     Robot-Assisted Placement of Pelvic Tissue Expander for Radiation after Prostatectomy and Cystectomy for Treatment of Prostate Cancer Biochemical Recurrence.
     Urology. 2018 Oct 29. pii: S0090-4295(18)31068.
     PubMed     Abstract available
     
     
     
157. ALBALA D, Manak MS, Varsanik JS, Rashid HH, et al
     Clinical proof-of-concept of a novel platform utilizing biopsy-derived live single cells, phenotypic biomarkers, and machine learning toward a precision risk stratification test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3+3 and 3+4).
     Urology. 2018 Oct 9. pii: S0090-4295(18)31073.
     PubMed     Abstract available
     
     
     September 2018
158. GIANNARINI G, Girometti R, Crestani A, Rossanese M, et al
     A prospective accuracy study of Prostate Imaging Reporting and Data System version 2 on multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer with whole-mount pathology.
     Urology. 2018 Sep 28. pii: S0090-4295(18)31054.
     PubMed     Abstract available
     
     
     
159. TEELING F, Raison MN, Shabbir MM, Yap MT, et al
     Testosterone therapy for high-risk prostate cancer survivors: a systematic review and meta-analysis.
     Urology. 2018 Sep 20. pii: S0090-4295(18)30993.
     PubMed     Abstract available
     
     
     
160. OBMANN VC, Pahwa S, Tabayayong W, Jiang Y, et al
     Diagnostic accuracy of a rapid biparametric MRI protocol for detection of histologically proven prostate cancer.
     Urology. 2018 Sep 7. pii: S0090-4295(18)30920.
     PubMed     Abstract available
     
     
     
161. MONDA SM, Vetter JM, Andriole GL, Fowler KJ, et al
     Cognitive Versus Software Fusion for MRI-targeted Biopsy: Experience Before and After Implementation of Fusion.
     Urology. 2018;119:115-120.
     PubMed     Abstract available
     
     
     
162. AGARWAL DK, Miest TS, Granberg CF, Frank I, et al
     Pediatric Robotic Prostatectomy and Pelvic Lymphadenectomy for Embryonal Rhabdomyosarcoma.
     Urology. 2018;119:143-145.
     PubMed     Abstract available
     
     
     August 2018
163. DIX DB, McDonald AM, Gordetsky JB, Nix JW, et al
     How Would MRI-Targeted Prostate Biopsy Alter Radiation Therapy Approaches in Treating Prostate Cancer?
     Urology. 2018 Aug 30. pii: S0090-4295(18)30911.
     PubMed     Abstract available
     
     
     
164. SU R, Xu G, Xiang L, Ding S, et al
     A novel scoring system for prediction of prostate cancer based on shear wave elastography and clinical parameters.
     Urology. 2018 Aug 29. pii: S0090-4295(18)30910.
     PubMed     Abstract available
     
     
     
165. HUNTLEY JH, Coley RY, Carter HB, Radhakrishnan A, et al
     Clinical evaluation of an individualized risk prediction tool for men on active surveillance for prostate cancer.
     Urology. 2018 Aug 29. pii: S0090-4295(18)30903.
     PubMed     Abstract available
     
     
     
166. CAPOGROSSO P, Capitanio U, Vertosick EA, Ventimiglia E, et al
     Temporal trend in incidental prostate cancer detection at surgery for benign prostatic hyperplasia.
     Urology. 2018 Aug 20. pii: S0090-4295(18)30783.
     PubMed     Abstract available
     
     
     
167. LEAPMAN MS, Wang R, Park HS, Yu JB, et al
     Association Between Prostate MRI and Observation for Low-Risk Prostate Cancer.
     Urology. 2018 Aug 11. pii: S0090-4295(18)30815.
     PubMed     Abstract available
     
     
     
168. HUEN KH, Bergman J
     Editorial Comment.
     Urology. 2018;118:133.
     PubMed    
     
     
     
169. ALPERT PF
     New Evidence for the Benefit of Prostate-specific Antigen Screening: Data From 400,887 Kaiser Permanente Patients.
     Urology. 2018;118:119-126.
     PubMed     Abstract available
     
     
     
170. KAOUK JH, Garisto J, Sagalovich D, Dagenais J, et al
     Robotic Single-port Partial Prostatectomy for Anterior Tumors: Transvesical Approach.
     Urology. 2018;118:242.
     PubMed     Abstract available
     
     
     July 2018
171. ZWAANS BMM, Bartolone SN, Chancellor MB, Nicolai H, et al
     Altered angiogenic growth factors in urine of prostate cancer survivors with radiation history and radiation cystitis.
     Urology. 2018 Jul 27. pii: S0090-4295(18)30779.
     PubMed     Abstract available
     
     
     
172. MAHRAN A, Turk A, Buzzy C, Wang M, et al
     Younger Men with Prostate Cancer have Lower Risk of Upgrading while on Active Surveillance: A Meta-analysis and Systematic Review of the Literature.
     Urology. 2018 Jul 26. pii: S0090-4295(18)30773.
     PubMed     Abstract available
     
     
     
173. KIM AH, Konety B, Chen Z, Schumacher F, et al
     COMPARATIVE EFFECTIVENESS OF LOCAL AND SYSTEMIC THERAPY FOR T4 PROSTATE CANCER.
     Urology. 2018 Jul 7. pii: S0090-4295(18)30630.
     PubMed     Abstract available
     
     
     
174. MODI PK, Kaufman SR, Qi J, Lane BR, et al
     National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms.
     Urology. 2018 Jul 7. pii: S0090-4295(18)30628.
     PubMed     Abstract available
     
     
     
175. LIU W, Patil D, Howard DH, Moore RH, et al
     Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United States.
     Urology. 2018;117:57-63.
     PubMed     Abstract available
     
     
     
176. LEUNG AK, Hugar L, Patil D, Wong L, et al
     The Clinical Course of Patients With Prostate-Specific Antigen >/=100 ng/ml: Insight Into a Potential Population for Targeted Prostate-Specific Antigen Screening.
     Urology. 2018;117:101-107.
     PubMed     Abstract available
     
     
     June 2018
177. HAAHR MK, Jensen CH, Toyserkani NM, Andersen DC, et al
     A 12-Month Follow-up After a Single Intracavernous Injection of Autologous Adipose-derived Regenerative Cells in Patients with Erectile Dysfunction Following Radical Prostatectomy: An Open-label Phase I Clinical Trial.
     Urology. 2018 Jun 27. pii: S0090-4295(18)30586.
     PubMed     Abstract available
     
     
     
178. MENG Y, Vetter JM, Parker AA, Arett CT, et al
     Improved Detection of Clinically Significant Prostate Cancer with Software-Assisted Systematic Biopsy Using MR/US Fusion in Patients with Negative Prostate MRI.
     Urology. 2018 Jun 26. pii: S0090-4295(18)30588.
     PubMed     Abstract available
     
     
     
179. RASKOLNIKOV D, Gore JL
     Editorial Comment.
     Urology. 2018;116:74-75.
     PubMed    
     
     
     
180. CURCI NE, Lane BR, Shankar PR, Noyes SL, et al
     Integration and Diagnostic Accuracy of 3T Nonendorectal coil Prostate Magnetic Resonance Imaging in the Context of Active Surveillance.
     Urology. 2018;116:137-143.
     PubMed     Abstract available
     
     
     
181. SHAH N, Ioffe V
     Re: Vetterlein et al.: State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update (Urology 2018;112:56-65).
     Urology. 2018;116:232.
     PubMed    
     
     
     
182. WELK B, Winick-Ng J, McClure JA, Lorenzo AJ, et al
     The Impact of the Choosing Wisely Campaign in Urology.
     Urology. 2018;116:81-86.
     PubMed     Abstract available
     
     
     May 2018
183. MEDINA LG, Cacciamani GE, Hernandez A, Landsberger H, et al
     Robotic Management of Recto-Urethral Fistulas after Focal Treatment for Prostate Cancer.
     Urology. 2018 May 22. pii: S0090-4295(18)30469.
     PubMed     Abstract available
     
     
     
184. KAYE DR, Qi J, Morgan TM, Linsell S, et al
     Association between Early Confirmatory Testing and the Adoption of Active Surveillance for Men with Favorable-Risk Prostate Cancer.
     Urology. 2018 May 21. pii: S0090-4295(18)30471.
     PubMed     Abstract available
     
     
     
185. BUELENS S, Van Praet C, Poelaert F, Van Huele A, et al
     Prospective, Randomized Controlled Trial Exploring the Effect of TachoSil(R) on Lymphocele Formation after Extended Pelvic Lymph Node Dissection in Prostate Cancer.
     Urology. 2018 May 15. pii: S0090-4295(18)30463.
     PubMed     Abstract available
     
     
     
186. ZHANG S, Li LH, Qiao HM, Yang X, et al
     Regulation of the Antioxidant-Response by MyoD Transcriptional Coactivator in Castration-Resistant Prostate Cancer Cells.
     Urology. 2018 May 3. pii: S0090-4295(18)30397.
     PubMed     Abstract available
     
     
     
187. LI Q, Xiang F, Lin X, Grajo JR, et al
     The Role of Imaging in Prostate Cancer Care Pathway: Novel Approaches to Urologic Management Challenges Along Ten Imaging Touch Points.
     Urology. 2018 May 3. pii: S0090-4295(18)30395.
     PubMed     Abstract available
     
     
     
188. MERRET C, Mannas M, Black PC, Zargar H, et al
     Magnet before the Needle: Commentary on MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis (PRECISION Trial).
     Urology. 2018 May 3. pii: S0090-4295(18)30393.
     PubMed    
     
     
     
189. PORPIGLIA F, Fiori C, Checcucci E, Amparore D, et al
     Augmented Reality Robot-assisted Radical Prostatectomy: Preliminary Experience.
     Urology. 2018;115:184.
     PubMed     Abstract available
     
     
     
190. HENRY MA, Howard DH, Davies BJ, Filson CP, et al
     Physician Reimbursement for Prostate Biopsies Falls as Procedures Shift From Offices to Facilities.
     Urology. 2018;115:96-101.
     PubMed     Abstract available
     
     
     
191. HEIDLER S, Drerup M, Lusuardi L, Bannert U, et al
     The Correlation of Prostate Volume and Prostate-specific Antigen Levels With Positive Bacterial Prostate Tissue Cultures.
     Urology. 2018;115:151-156.
     PubMed     Abstract available
     
     
     
192. FULLER TW, Ristau BT, Tepe SM, Benoit RM, et al
     Characterizing Clinically Meaningful Changes in Lower Urinary Tract Symptoms Using the American Urological Association Symptom Index.
     Urology. 2018;115:139-143.
     PubMed     Abstract available
     
     
     
193. MEYER AR, Joice GA, Schwen ZR, Partin AW, et al
     Initial Experience Performing In-office Ultrasound-guided Transperineal Prostate Biopsy Under Local Anesthesia Using the PrecisionPoint Transperineal Access System.
     Urology. 2018;115:8-13.
     PubMed     Abstract available
     
     
     
194. KARSH LI, Gross ET, Pieczonka CM, Aliotta PJ, et al
     Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data.
     Urology. 2018;115:39-44.
     PubMed     Abstract available
     
     
     
195. BRASSETTI A, D'Elia G
     Reply by the Authors.
     Urology. 2018;115:189.
     PubMed    
     
     
     April 2018
196. LUCKENBAUGH AN, Hollenbeck BK, Kaufman SR, Yan P, et al
     Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer.
     Urology. 2018 Apr 6. pii: S0090-4295(18)30300.
     PubMed     Abstract available
     
     
     
197. VELASQUEZ MC, Chinea FM, Kwon D, Prakash NS, et al
     The Influence of Ethnic Heterogeneity on Prostate Cancer Mortality after Radical Prostatectomy in Hispanic/Latino Men: A Population-Based Analysis.
     Urology. 2018 Apr 6. pii: S0090-4295(18)30293.
     PubMed     Abstract available
     
     
     
198. DE RIESE W, Verlage K, Grand R, de Riese CS, et al
     Re: Turini et al.: The State of Prescreening Discussions About Prostate-specific Antigen Testing Following Implementation of the 2012 United States Preventive Services Task Force Statement (Urology 2017;104:122-130).
     Urology. 2018;114:246.
     PubMed    
     
     
     
199. NEAD KT, Boldbaatar N, Yang DD, Sinha S, et al
     Association of Androgen Deprivation Therapy and Thromboembolic Events: A Systematic Review and Meta-analysis.
     Urology. 2018;114:155-162.
     PubMed     Abstract available
     
     
     
200. FRIEDL A, Schneeweiss J, Sevcenco S, Eredics K, et al
     In-bore 3.0-T Magnetic Resonance Imaging-guided Transrectal Targeted Prostate Biopsy in a Repeat Biopsy Population: Diagnostic Performance, Complications, and Learning Curve.
     Urology. 2018;114:139-146.
     PubMed     Abstract available
     
     
     
201. SRIVASTAVA A, Joice GA, Patel HD, Manka MG, et al
     Impact of Adjuvant Radiation on Artificial Urinary Sphincter Durability in Postprostatectomy Patients.
     Urology. 2018;114:212-217.
     PubMed     Abstract available
     
     
     
202. SHAPIRO DD, Goodspeed DC, Bushman W
     Urosymphyseal Fistulas Resulting From Endoscopic Treatment of Radiation-induced Posterior Urethral Strictures.
     Urology. 2018;114:207-211.
     PubMed     Abstract available
     
     
     March 2018
203. KESCH C, Black PC
     Filling a True Unmet Need: a New Therapy for Non-Metastatic Castrate Resistant Prostate Cancer. Commentary on: Apalutamide Treatment and Metastasis-Free Survival in Prostate Cancer.
     Urology. 2018 Mar 26. pii: S0090-4295(18)30260.
     PubMed    
     
     
     
204. BJURLIN MA, Turkbey B, Rosenkrantz AB, Gaur S, et al
     Imaging the High-Risk Prostate Cancer Patient: Current and Future Approaches to Staging.
     Urology. 2018 Mar 12. pii: S0090-4295(17)31305.
     PubMed     Abstract available
     
     
     
205. DELAY KJ, Haney NM, Chiang J, Stewart C, et al
     Comparison of Adjuvant Radiation Therapy Before or After Artificial Urinary Sphincter Placement: A Multi-Institutional, Retrospective Analysis.
     Urology. 2018;113:160-165.
     PubMed     Abstract available
     
     
     
206. WEAVER JK, Kim EH, Vetter JM, Shetty A, et al
     Prostate Magnetic Resonance Imaging Provides Limited Incremental Value Over the Memorial Sloan Kettering Cancer Center Preradical Prostatectomy Nomogram.
     Urology. 2018;113:119-128.
     PubMed     Abstract available
     
     
     
207. CARPENTER CP, Gleason JM
     When Chemotherapy Is Not Enough-Management of Prostatic Embryonal Rhabdomyosarcoma in an Infant.
     Urology. 2018;113:200-202.
     PubMed     Abstract available
     
     
     
208. RADADIA KD, Farber NJ, Shinder B, Polotti CF, et al
     Management of Postradical Prostatectomy Urinary Incontinence: A Review.
     Urology. 2018;113:13-19.
     PubMed     Abstract available
     
     
     
209. KO KJ, Lee CU, Kim TH, Suh YS, et al
     Predictive Factors of De Novo Overactive Bladder After Artificial Urinary Sphincter Implantation in Men With Postprostatectomy Incontinence.
     Urology. 2018;113:215-219.
     PubMed     Abstract available
     
     
     February 2018
210. RADHAKRISHNAN A, Grande D, Mitra N, Pollack CE, et al
     Which Patients Report That Their Urologists Advised Them to Forgo Initial Treatment for Prostate Cancer?
     Urology. 2018 Feb 22. pii: S0090-4295(18)30160.
     PubMed     Abstract available
     
     
     
211. WOJNO L, Minutella C, Moylan D, Bush A, et al
     Specimen Provenance Testing Identifies Contamination That Affects Molecular Prognostic Assay Results in Prostate Cancer Biopsy Specimens.
     Urology. 2018 Feb 21. pii: S0090-4295(18)30162.
     PubMed     Abstract available
     
     
     
212. SATAKE Y, Kaiho Y, Saito H, Yamada T, et al
     Estimated Minimal Residual Membranous Urethral Length on Preoperative Magnetic Resonance Imaging Can Be a New Predictor for Continence After Radical Prostatectomy.
     Urology. 2018;112:138-144.
     PubMed     Abstract available
     
     
     
213. KAYE DR, Syrjamaki J, Ellimoottil C, Schervish EW, et al
     Use of Routine Home Health Care and Deviations From an Uncomplicated Recovery Pathway After Radical Prostatectomy.
     Urology. 2018;112:74-79.
     PubMed     Abstract available
     
     
     
214. VETTERLEIN MW, Dalela D, Sammon JD, Karabon P, et al
     State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update.
     Urology. 2018;112:56-65.
     PubMed     Abstract available
     
     
     
215. ELKHOURY FF, Simopoulos DN, Marks LS
     Targeted Prostate Biopsy in the Era of Active Surveillance.
     Urology. 2018;112:12-19.
     PubMed     Abstract available
     
     
     January 2018
216. CANCIAN M, Renzulli JF 2nd
     Non Metastatic Castration Resistant Prostate Cancer: a Modern Perspective.
     Urology. 2018 Jan 18. pii: S0090-4295(18)30044.
     PubMed     Abstract available
     
     
     
217. WALLIS CJD, Satkunasivam R, Herschorn S, Law C, et al
     Association between Primary Local Treatment and Non-Prostate Cancer Mortality in Men with Non-Metastatic Prostate Cancer.
     Urology. 2018 Jan 2. pii: S0090-4295(17)31330.
     PubMed     Abstract available
     
     
     
218. BRASSETTI A, Lombardo R, Emiliozzi P, Cardi A, et al
     Prostate-specific Antigen Density Is a Good Predictor of Upstaging and Upgrading, According to the New Grading System: The Keys We Are Seeking May Be Already in Our Pocket.
     Urology. 2018;111:129-135.
     PubMed     Abstract available
     
     
     
219. CHRISTIDIS D, McGrath S, Leaney B, O'Sullivan R, et al
     Interpreting Prostate Multiparametric Magnetic Resonance Imaging: Urologists' Guide Including Prostate Imaging Reporting and Data System.
     Urology. 2018;111:136-138.
     PubMed     Abstract available
     
     
     December 2017
220. TANG V, Campbell P, Pattison DA
     Lymphangitic Carcinomatosis From Prostate Cancer Identified with Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging.
     Urology. 2017 Dec 29. pii: S0090-4295(17)31327.
     PubMed     Abstract available
     
     
     
221. WERNEBURG GT, Kongnyuy M, Halpern DM, Salcedo JM, et al
     Effects of Focal Versus Total Cryotherapy and Minimum Tumor Temperature on Patient-Reported Quality of Life as Compared to Active Surveillance in Prostate Cancer Patients.
     Urology. 2017 Dec 22. pii: S0090-4295(17)31302.
     PubMed     Abstract available
     
     
     
222. KAHOKEHR AA, Peterson AC
     Unmasking of Urinary-Pubic Symphysis Fistula (UPF) after Implantation of Artificial Urinary Sphincter in Prostate Cancer Survivors - User Beware. Url-D-17-02187.
     Urology. 2017 Dec 22. pii: S0090-4295(17)31301.
     PubMed     Abstract available
     
     
     
223. ULLMAN D, Dorn D, Rais-Bahrami S, Gordetsky J, et al
     Clinical Utility and Biologic implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer.
     Urology. 2017 Dec 7. pii: S0090-4295(17)31219.
     PubMed     Abstract available
     
     
     November 2017
224. WALLIS CJD, Satkunasivam R, Saskin R, Bansal S, et al
     Population-Based Analysis of Treatment Toxicity among Men with Castration-Resistant Prostate Cancer: a Phase IV Study.
     Urology. 2017 Nov 27. pii: S0090-4295(17)31221.
     PubMed     Abstract available
     
     
     
225. CHUNG PH, Esposito P, Wessells H, Voelzke BB, et al
     Incidence of Stress Urinary Incontinence Following Posterior Urethroplasty for Radiation-Induced Urethral Strictures.
     Urology. 2017 Nov 27. pii: S0090-4295(17)31222.
     PubMed     Abstract available
     
     
     
226. 
     Erratum to "Postoperative Adjuvant and Salvage Radiotherapy for Prostate Cancer: Impact on Freedom From Biochemical Relapse and Survival".
     Urology. 2017 Nov 20. pii: S0090-4295(17)31088.
     PubMed    
     
     
     
227. BJURLIN MA, Rosenkrantz AB, Sarkar S, Lepor H, et al
     Prediction of Prostate Cancer Risk among Men Undergoing Combined MRI-Targeted and Systematic Biopsy Using Novel Pre-Biopsy Nomograms That Incorporate MRI Findings.
     Urology. 2017 Nov 16. pii: S0090-4295(17)31185.
     PubMed     Abstract available
     
     
     
228. BARQAWI A, Huebner E, Krughoff K, O'Donnell CI, et al
     Prospective Outcome Analysis of the Safety and Efficacy of Partial and Complete Cryoablation in Organ-Confined Prostate Cancer.
     Urology. 2017 Nov 7. pii: S0090-4295(17)31163.
     PubMed     Abstract available
     
     
     October 2017
229. ZHONG W, Smith B, Haghighi K, Mancuso P, et al
     Systematic Review of Decision Aids for the Management of Men with Localized Prostate Cancer.
     Urology. 2017 Oct 31. pii: S0090-4295(17)31154.
     PubMed     Abstract available
     
     
     
230. SHARMA V, Yousefi K, Haddad Z, Buerki C, et al
     Gene Expression Correlates of Site-Specific Metastasis among Men with Lymph Node Positive Prostate Cancer Treated with Radical Prostatectomy: a Case Series.
     Urology. 2017 Oct 24. pii: S0090-4295(17)31099.
     PubMed     Abstract available
     
     
     
231. KENIGSBERG AP, Llukani E, Deng FM, Melamed J, et al
     The Use of MRI to Predict Oncological Control among Candidates for Focal Ablation of Prostate Cancer.
     Urology. 2017 Oct 20. pii: S0090-4295(17)31097.
     PubMed     Abstract available
     
     
     
232. NGUYEN A, O'Leary MP
     Re: Deebel et al.: Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges (Urology 2017, http://dx.doi.org/doi:10.1016/j.urology.2017.08.032).
     Urology. 2017 Oct 16. pii: S0090-4295(17)31076.
     PubMed    
     
     
     September 2017
233. QURESHI ZP, Sartor O, Bennett CL
     Calling Order to Chaos: Treatment Decision Making in Metastatic Castrate-resistant Prostate Cancer.
     Urology. 2017 Sep 20. pii: S0090-4295(17)30750.
     PubMed    
     
     
     
234. SHORE N, Heidenreich A, Saad F
     Author Response on the Manuscript Titled "Calling Order to Chaos: Treatment Decision Making in Metastatic Castrate-resistant Prostate Cancer" (#URL-D-17-01121).
     Urology. 2017 Sep 20. pii: S0090-4295(17)30751.
     PubMed    
     
     
     
235. GOLOMBOS DM, Ayangbesan A, O'Malley P, Lewicki P, et al
     The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: a Prospective, Pilot Study.
     Urology. 2017 Sep 6. pii: S0090-4295(17)30957.
     PubMed     Abstract available
     
     
     
236. WIENER S, Haddock P, Cusano J, Staff I, et al
     Incidence of Clinically Significant Prostate Cancer after a Diagnosis of Atypical Small Acinar Proliferation (ASAP), High Grade Prostatic Intraepithelial Neoplasia (HGPIN), or Benign Tissue.
     Urology. 2017 Sep 6. pii: S0090-4295(17)30958.
     PubMed     Abstract available
     
     
     
237. DEEBEL NA, Morin JP, Autorino R, Vince R, et al
     Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges.
     Urology. 2017 Sep 4. pii: S0090-4295(17)30906.
     PubMed     Abstract available
     
     
     August 2017
238. BOESEN L, Norgaard N, Logager V, Balslev I, et al
     Where Do TRUS- and MRI Guided Biopsies Miss Significant Prostate Cancer?
     Urology. 2017 Aug 30. pii: S0090-4295(17)30899.
     PubMed     Abstract available
     
     
     
239. FRIEDL A, Stangl K, Bauer W, Kivaranovic D, et al
     Prostate-Specific Antigen Parameters and Prostate Health Index Enhance Prostate Cancer Prediction with the in-Bore 3-T MRI-Guided Transrectal Targeted Prostate Biopsy after Negative 12-Core Biopsy.
     Urology. 2017 Aug 24. pii: S0090-4295(17)30880.
     PubMed     Abstract available
     
     
     
240. OROM H, Biddle C, Underwood W 3rd, Homish GG, et al
     Racial/Ethnic and Socioeconomic Disparities in Prostate Cancer Survivors' Prostate-Specific Quality of Life.
     Urology. 2017 Aug 22. pii: S0090-4295(17)30866.
     PubMed     Abstract available
     
     
     
241. BHINDI B, Carlson RE, Mason RJ, Schulte PJ, et al
     Long-Term Follow Up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-Confined Prostate Cancer with a Positive Surgical Margin.
     Urology. 2017 Aug 17. pii: S0090-4295(17)30853.
     PubMed     Abstract available
     
     
     
242. AAS K, Axcrona K, Kvale R, Moller B, et al
     10-Year Mortality in Men with Non-Metastatic Prostate Cancer in Norway.
     Urology. 2017 Aug 17. pii: S0090-4295(17)30860.
     PubMed     Abstract available
     
     
     
243. SHORE N, Heidenreich A, Saad F
     Predicting Response and Recognizing Resistance: Improving Outcomes in Patients with Castration-Resistant Prostate Cancer.
     Urology. 2017 Aug 7. pii: S0090-4295(17)30745.
     PubMed     Abstract available
     
     
     
244. STRUSS WJ, Black PC
     Commentary on: Abiraterone Plus Prednisolone in Metastatic, Castration-Sensitive Prostate Cancer.
     Urology. 2017 Aug 7. pii: S0090-4295(17)30779.
     PubMed    
     
     
     July 2017
245. ZACHO HD, Gade M, Mortensen JC, Bertelsen H, et al
     Bone Scan Index is an Independent Predictor for Time to Castration-Resistant Prostate Cancer in Newly Diagnosed Prostate Cancer: a Prospective Study.
     Urology. 2017 Jul 28. pii: S0090-4295(17)30759.
     PubMed     Abstract available
     
     
     
246. ZACHO HD, Petersen LJ
     Reply by the authors to the Editorial on: Zacho HD, Gade M, Mortensen JC, Bertelsen H, Boldsen SK, Petersen LJ. Bone scan index is an independent predictor for time to castration resistant prostate cancer in newly diagnosed prostate cancer: A prospect
     Urology. 2017 Jul 26. pii: S0090-4295(17)30760.
     PubMed    
     
     
     
247. HORIGUCHI A, Shinchi M, Nakamura A, Wada T, et al
     Pilot Study of Prostate Cancer Angiogenesis Imaging Using a Photoacoustic Imaging System.
     Urology. 2017 Jul 19. pii: S0090-4295(17)30733.
     PubMed     Abstract available
     
     
     June 2017
248. SKOLARUS TA, Ragnoni JA, Garlinghouse C, Schafenacker A, et al
     Multilingual Self-Management Resources for Prostate Cancer Survivors and Their Partners: Results of a Long-Term Academic-State Health Department Partnership to Promote Survivorship Care.
     Urology. 2017 Jun 23. pii: S0090-4295(17)30637.
     PubMed     Abstract available
     
     
     
249. GORIN MA, Pienta KJ, Pomper MG, Rowe SP, et al
     Prostate Cancer Local Recurrence Detected with Both 18F-Fluciclovine and PSMA-Targeted 18F-DCFPyL PET/CT.
     Urology. 2017 Jun 19. pii: S0090-4295(17)30635.
     PubMed     Abstract available
     
     
     
250. MANNAS M, Chedgy E, Black PC
     You Pays Your Money, You Takes Your Choice: Functional Outcomes Following Curative Treatment for Clinically Localized Prostate Cancer.
     Urology. 2017 Jun 15. pii: S0090-4295(17)30625.
     PubMed    
     
     
     
251. GRIVAS N, van der Roest R, Tillier C, Schouten D, et al
     Patterns of Benign Prostate Hyperplasia Based on Magnetic Resonance Imaging are Correlated with Lower Urinary Tract Symptoms and Continence in Men Undergoing a Robot-Assisted Radical Prostatectomy for Prostate Cancer.
     Urology. 2017 Jun 7. pii: S0090-4295(17)30604.
     PubMed     Abstract available
     
     
     May 2017
252. HEGDE JV, Veruttipong D, Said JW, Reiter RE, et al
     Prostate Cancer Antigen 3 (PCA3) Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-Free Survival in Clinically-Localized, Intermediate- and High-Risk Prostate Cancer.
     Urology. 2017 May 25. pii: S0090-4295(17)30565.
     PubMed     Abstract available
     
     
     April 2017
253. DAVIS K, Bellini P, Hagerman C, Zinar R, et al
     Physicians' Perceptions of Factors Influencing the Treatment Decision-Making Process for Men with Low-Risk Prostate Cancer.
     Urology. 2017 Apr 25. pii: S0090-4295(17)30391.
     PubMed     Abstract available
     
     
     
254. CANTIELLO F, Gangemi V, Cascini GL, Calabria F, et al
     Diagnostic Accuracy of 64Cu-PSMA PET/CT for Primary Lymph Node Staging of Intermediate to High Risk Prostate Cancer: Our Preliminary Experience.
     Urology. 2017 Apr 21. pii: S0090-4295(17)30385.
     PubMed     Abstract available
     
     
     
255. XIA L, Zeh R, Mizelle J, Newton A, et al
     Near-Infrared Intraoperative Molecular Imaging Can Identify Metastatic Lymph Nodes in Prostate Cancer.
     Urology. 2017 Apr 21. pii: S0090-4295(17)30386.
     PubMed     Abstract available
     
     
     
256. MANNING TG, Cheung E, Perera M, Christidis D, et al
     Atypical Small Acinar Proliferation and High Grade Prostatic Intraepithelial Neoplasia in the Era of Multi-Parametric MRI: a Contemporary Review.
     Urology. 2017 Apr 21. pii: S0090-4295(17)30388.
     PubMed     Abstract available
     
     
     
257. POELAERT F, Verbaeys C, Rappe B, Kimpe B, et al
     Cytoreductive Prostatectomy for Metastatic Prostate Cancer: First Lessons Learned From the Multicentric Prospective LoMP Trial.
     Urology. 2017 Apr 20. pii: S0090-4295(17)30372.
     PubMed     Abstract available
     
     
     
258. JUE JS, Barboza MP, Prakash NS, Venkatramani V, et al
     Re-Examining PSA Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy.
     Urology. 2017 Apr 18. pii: S0090-4295(17)30368.
     PubMed     Abstract available
     
     
     
259. GUERRIOS-RIVERA L, Howard L, Frank J, De Hoedt A, et al
     Is BMI the Best Adiposity Measure for Prostate Cancer Risk? Results From a VA Biopsy Cohort.
     Urology. 2017 Apr 10. pii: S0090-4295(17)30347.
     PubMed     Abstract available
     
     
     March 2017
260. JOHNSTON J, Struss WJ, Black PC
     Padeliporfin Vascular-Targeted Photodynamic Therapy Versus Active Surveillance in Men with Low-Risk Prostate Cancer (Clin1001 PCM301): an Open-Label, Phase 3, Randomised Control Trial.
     Urology. 2017 Mar 22. pii: S0090-4295(17)30274.
     PubMed    
     
     
     
261. STRUSS WJ, Black PC
     Radiation with or Without Antiandrogen Therapy in Recurrent Prostate Cancer.
     Urology. 2017 Mar 22. pii: S0090-4295(17)30275.
     PubMed    
     
     
     
262. PAKZAD R, Safiri S
     Unexplained Bone Pain is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: a Prospective Study; Methodological Issues.
     Urology. 2017 Mar 21. pii: S0090-4295(17)30272.
     PubMed    
     
     
     
263. ZACHO HD, Morch CD, Barsi T, Mortensen JC, et al
     Reply to Letter-to-the-Editor: Unexplained Bone Pain is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: a Prospective Study, Published in Urology. 2017 Jan;99:148-154.
     Urology. 2017 Mar 20. pii: S0090-4295(17)30269.
     PubMed    
     
     
     
264. JOSHI A, Nicholson C, Rhee H, Gustafson S, et al
     Incidental Malignancies identified during staging for Prostate Cancer with 68Ga -PSMA HBED-CC PET imaging.
     Urology. 2017 Mar 20. pii: S0090-4295(17)30271.
     PubMed     Abstract available
     
     
     
265. LU AJ, Syed JS, Nguyen KA, Nawaf CB, et al
     Negative Multi-Parametric MRI of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy.
     Urology. 2017 Mar 16. pii: S0090-4295(17)30247.
     PubMed     Abstract available
     
     
     
266. PAKZAD R, Safiri S
     Cognitive Effects of Androgen Deprivation Therapy in Men with Advanced Prostate Cancer: Methodological Issues.
     Urology. 2017 Mar 15. pii: S0090-4295(17)30244.
     PubMed    
     
     
     
267. 
     Erratum to "Predictors of Time to Metastasis in Castration-resistant Prostate Cancer".
     Urology. 2017 Mar 14. pii: S0090-4295(17)30113.
     PubMed    
     
     
     February 2017
268. JOHNSON SC, Packiam VT, Golan S, Cohen AJ, et al
     The Effect of Obesity on Perioperative Outcomes for Open and Minimally Invasive Prostatectomy.
     Urology. 2017;100:111-116.
     PubMed     Abstract available
     
     
     
269. BORHAN W, Epstein JI
     Significance of Gleason Score 7 With Tertiary Pattern 5 at Radical Prostatectomy.
     Urology. 2017;100:175-179.
     PubMed     Abstract available
     
     
     
270. KOMINSKY HD, Bashline M, Eun D, Pontari MA, et al
     Use of Age and Medical Comorbidity to Assess Long-term Other-cause Mortality Risk in a Cohort of Men Undergoing Prostate Biopsy at an Academic Medical Center.
     Urology. 2017;100:169-174.
     PubMed     Abstract available
     
     
     January 2017
271. ZARGAR-SHOSHTARI K, Lawrentschuk N, Zargar H
     Robotic Prostatectomy Delivers on the Promise of Minimally Invasive Surgery: Commentary on: Robot-assisted Laparoscopic Prostatectomy Versus Open Radical Retropubic Prostatectomy: Early Outcomes from a Randomised Controlled Phase 3 Study.
     Urology. 2017;99:3-4.
     PubMed    
     
     
     August 2016
272. LIU JS, Hofer MD, Sheth KR, Cordon BH, et al
     Improving Outcomes of Bulbomembranous Urethroplasty for Radiation-Induced Urethral Strictures in Post-Urolume Era.
     Urology. 2016 Aug 2. pii: S0090-4295(16)30459.
     PubMed     Abstract available
     
     
     July 2016
273. HOFER MD, Morey AF, Sheth K, Tausch TJ, et al
     Low Serum Testosterone Level Predisposes to Artificial Urinary Sphincter Cuff Erosion.
     Urology. 2016 Jul 20. pii: S0090-4295(16)30422.
     PubMed     Abstract available
     
     
     May 2016
274. QUINTANA L, Ward A, Gerrin SJ, Genega EM, et al
     Gleason Misclassification Rate Is Independent of Number of Biopsy Cores in Systematic Biopsy.
     Urology. 2016;91:143-9.
     PubMed     Abstract available
     
     
     
275. KARATZAS AD, Zachos I, Mitrakas L, Dimitropoulos K, et al
     Generalized Lymphadenopathy of Prostate Adenocarcinoma Origin. A Case Series.
     Urology. 2016;91:e3-4.
     PubMed     Abstract available
     
     
     
276. DASON S, Allard CB, Wright I, Shayegan B, et al
     Transurethral Resection of the Prostate Biopsy of Suspected Anterior Prostate Cancers Identified by Multiparametric Magnetic Resonance Imaging: A Pilot Study of a Novel Technique.
     Urology. 2016;91:129-35.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: